MalarVx Analysis: $2M Raised
What is MalarVx?
A malaria vaccine company with a new approach
Location
Seattle, United States
Employees
1-10
Founded
2012
Product Features & Capabilities
- Vaccine development
- In vitro mosquito-stages research
- Clinical trials pipeline
- Scientific publications
Use Cases
Develop vaccines targeting malaria; Conduct clinical trials for vaccine efficacy; Research mosquito stages to inform vaccine design; Publish findings to advance malaria research; Collaborate with health organizations for malaria eradication
See something that needs updating? Suggest edits to this profile.